|
AU2014240250A1
|
|
Combination therapy with organic arsenicals
|
|
US2014004192A1
|
|
Pharmaceutical formulations of indibulin and uses thereof
|
|
US2013196000A1
|
|
Combination therapy including isophosphoramide mustard, analogs, or salts thereof
|
|
TW201113266A
|
|
Pharmaceutical formulations for indibulin
|
|
WO2010021928A1
|
|
Organoarsenic compounds and methods for the treatment of cancer
|
|
CN104490900A
|
|
Synthesis And Formulations Of Salts Of Isophosphoramide Mustard And Analogs Thereof
|
|
WO2009075870A1
|
|
Compounds and methods for the treatment of cancer
|
|
CN101903029A
|
|
Combination therapy with organic arsenicals
|
|
BRPI0809999A2
|
|
Isophosphoramide mustard salts and analogs of the same
|
|
TW200838521A
|
|
Indibulin therapy
|
|
AU2007325797A1
|
|
Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
|
|
TW200829261A
|
|
Method for controlling angiogenesis in animals
|
|
US2011118209A1
|
|
Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
|
|
EP1919564A2
|
|
Compounds and methods for the treatment of cancer
|
